KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Global Medical REIT (GMRE) Cash from Financing Activities (2016 - 2025)

Historic Cash from Financing Activities for Global Medical REIT (GMRE) over the last 14 years, with Q3 2025 value amounting to -$16.2 million.

  • Global Medical REIT's Cash from Financing Activities fell 27744.89% to -$16.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $16.2 million, marking a year-over-year increase of 14276.98%. This contributed to the annual value of -$21.9 million for FY2024, which is 8477.89% up from last year.
  • Global Medical REIT's Cash from Financing Activities amounted to -$16.2 million in Q3 2025, which was down 27744.89% from $18.7 million recorded in Q2 2025.
  • Global Medical REIT's Cash from Financing Activities' 5-year high stood at $58.3 million during Q2 2022, with a 5-year trough of -$84.0 million in Q2 2023.
  • In the last 5 years, Global Medical REIT's Cash from Financing Activities had a median value of $5.6 million in 2022 and averaged $2.1 million.
  • In the last 5 years, Global Medical REIT's Cash from Financing Activities soared by 79903.16% in 2021 and then plummeted by 44585.94% in 2023.
  • Global Medical REIT's Cash from Financing Activities (Quarter) stood at $11.5 million in 2021, then crashed by 239.07% to -$16.0 million in 2022, then grew by 0.87% to -$15.9 million in 2023, then soared by 100.96% to $153000.0 in 2024, then plummeted by 10720.26% to -$16.2 million in 2025.
  • Its Cash from Financing Activities stands at -$16.2 million for Q3 2025, versus $18.7 million for Q2 2025 and $13.6 million for Q1 2025.